RxDoctor Payments Data

Dominic Rizzo, DPM

Foot & Ankle Surgery · Blue Ash, OHNPI 1043283047

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (43.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by DNE LLC at 46.5% of the total. Reporting peaked in 2019 at $79,795 and has fallen 73.6% since, to $21,076 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$302,635in general payments, 2019–2025

Across 236 payments — averaging $1282.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • DNE LLC$141K
  • Johnson & Johnson$80K
  • Crossroads Extremity Systems, LLC$52K
  • Integra Lifesciences Corporation$8K
  • Bioness Inc$5K
  • Bioventus LLC$4K
  • plus $13K from 29 others

What the payments were for

  • Royalty or licence$132,08644%
  • Consulting fees$81,00027%
  • Speaking & faculty fees$59,78820%
  • Travel & lodging$17,9466%
  • Food & beverage$6,6912%
  • Education$5,1252%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$302,635 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.

See all foot & ankle surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$7,356,815
Medicare patients
359
Services billed
7,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen244$2,063
Gentamicin Sulfate43$2,035
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav66$1,127
Gabapentin65$708
Doxycycline Hyclate36$571
Amoxicillin52$539
Doxycycline Monohydrate18$468
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$396
Diclofenac Sodium19$383
Silver Sulfadiazine29$372
Ibuprofen51$330
Levofloxacin25$300
SsdSilver Sulfadiazine25$211
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$168
Methylprednisolone12$32

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Blue Ash

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →